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Abstract   
BACKGROUND: Maternal depression complicates a large proportion of pregnancies. Current 
evidence shows numerous harmful effects on the offspring. Reviews, which include depression, 
concluded that stress has harmful effects on the offspring’s outcomes neuro-cognitive 
development, temperament traits and mental disorders.  
OBJECTIVE: This mini review of recent studies, sought to narrow the scope of exposure and 
identify studies specifically assessing prenatal depression and offspring neuropsychiatric 
outcomes.  
STUDY ELIGIBILITY CRITERIA: The review included longitudinal, cohort, cross-sectional, 
clinical, quasi-experimental, epidemiological or intervention study designs published in English 
from 2014-2018. 
PARTICIPANTS: Study populations included mother-child dyads, mother-father-child triads, 
mother-alternative caregiver-child triads and family studies utilizing  sibling comparisons.  
METHODS: We searched PubMED and Web of Science. Study inclusion and data extraction 
were based on standardized templates. The quality of evidence was assessed using the 
Newcastle-Ottawa Scale(NOS).  
RESULTS: Thirteen studies examining neuropsychiatric outcomes were included. We judged the 
evidence to be moderate to high quality.  
CONCLUSIONS: Our review supports that maternal prenatal depression is associated with 
neuropsychiatric adversities in children.  
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IMPLICATIONS: Future investigations should unravel the biological underpinnings and target 
timely interventions as early in pregnancy as possible to prevent offspring neuropsychiatric 
harms. 
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Introduction  
Early life environmental adversities may exert consequences upon developing cells, tissues, and 
organs, their structure and function. These biological alterations may result in phenotypic 
differences between individuals that persist throughout the lifespan – a developmental plasticity 
phenomenon called ‘prenatal programming’(1–4).  
Maternal depression complicates a large proportion of pregnancies with 7.4%-20% of women 
experiencing major or minor depression, dysthymia or clinically significant depressive 
symptomatology  during pregnancy(5).
 
Yet, a large proportion of pregnant women with  
depression remain undetected(6). This does not merely reflect a lack of systematic screening, but 
also an unwillingness of women to admit experiencing depressive symptoms(7). Nearly half of 
women reported feeling too embarrassed to confess to a healthcare professional that they are not 
feeling well and almost one-third were afraid that if they divulged their feelings, their baby 
would be taken away(7). Many of the rest feared repercussions such as  stigma(7).  
Due to the high prevalence, maternal depression is a major complication of pregnancy and 
childbirth. Strongly predicted by prenatal depression(8), maternal postpartum depression also 
carries adverse consequences for the offspring(9). One systematic review and meta-analysis of 
studies published between 2010-2015, concluded that offspring of women with untreated 
depression during pregnancy were 56% more likely to be born preterm(< 37 gestational weeks) 
and 96% more likely to be born with a low birth weight(< 2.5 kg)(10). Another review of studies 
published up to2015 focused on the effects of maternal untreated pregnancy depression on a 
series of offspring outcomes ranging from birth outcomes and physiological effects to cognitive 
and psychopathological effects(11). While the evidence of the reviewed studies showed a 
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number of harmful effects on the offspring, yet the evidence was controversial, particularly 
regarding preterm birth and low birth weight(11). Pregnancy factors such as maternal age, 
gestation length, current maternal depressive status, pre-pregnancy obesity, gestational 
diabetes/hypertension, pre-eclampsia, and substance use during pregnancy, if not properly 
considered, may inflate the to the body of evidence. Yet, another recent review of studies 
published between 2010-2017  concluded that maternal stress in pregnancy, which included  
depression,  has harmful effects on the offspring’s  neuro-cognitive development, negative 
affectivity, difficult temperament and mental health(2). As it is important to consider the 
althernative possibilities, numerous reviews explore the harmful effects of offspring exposure to 
pharmacologically treated(e.g. SSRIs) maternal prenatal depression(12–15).  
To the best of our knowledge, no reviews have focused specifically on the consequences of 
prenatal depression on offspring neuropsychiatric outcomes. Hence, the objective of this review 
was to assess all recent studies assessing prenatal depression and offspring neuropsychiatric 
outcomes. We evaluate the quality of the evidence of the reviewed studies using the Newcastle-
Ottawa Scale assessment(NOS).  To deepen the discussion, we examine whether potential 
harmful effects of maternal depression on offspring neuropsychiatric outcomes are specific to the 
pregnancy period or explained by postnatal depression and whether a specific window of 
vulnerability exists when the effects of prenatal depression on offspring neuropsychiatric 
outcomes are most detrimental. Furthermore, we briefly explore the potential mechanisms 
through which prenatal depression may exert harmful consequences on offspring 
neuropsychiatric development. Lastly, we highlight treatment methods for prenatal depression, 
thereby possibly preventing offspring neurodevelopmental harm. 
Methods  
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We searched Pubmed/MEDLINE and Web of Science databases for human longitudinal, cohort, 
and cross-sectional studies, published between January 2014 and February 2018 in English, with 
either clinical, quasi-experimental, epidemiological or intervention study designs.  
We included studies focusing on mother-child dyads, mother-father/alternate caregiver-child 
triads. Study criteria included  maternal prenatal depression with any depressive disorder 
diagnosis identified via medical registries, psychiatric interview, or depressive symptoms 
measured with self-report questionnaires. We excluded studies that used antidepressant use as 
the sole exposure measure, reported only on lifetime history of depression, used retrospective 
self-reports or unclearly defined exposure. We excluded studies that used other forms of 
psychological stress or only a combined exposure measure, such as a depression and anxiety 
mean score. For offspring neuropsychiatric outcomes, we considered internalizing and 
externalizing problems, including anxiety, depression, attention, conduct problems, Attention 
Deficit Hyperactivity Disorder(ADHD), autism spectrum disorders and schizophrenia. 
We utilized RevMan5 software to generate the PRISMA flow diagram(16) that describes the 
study selection process(Figure 1). The studies’ characteristics, participant demographics and data 
were systematically collected from each study using a standardized template. 
We assessed risk of bias and the methodological quality in non-randomized, non-intervention, 
observational studies using NOS, a recommended method from the Cochrane Handbook of 
Systematic reviews(17,18).   
Results  
The sensitive search strategy applied produced 5712 articles(1083=Pubmed, 4629=Web of 
Science) for all studies up until February 2018. Refining the results to publications from 2014-
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2018, rendered 766 articles(PubMed, n=135; Web of Science, n=631 for title and abstract 
review.  Further hand searching of reference lists and other sources augmented the search 
findings(n=9). We included 13 empirical studies that examined prenatal depression and 
neuropsychiatric outcomes in offspring. See Figure 1 for the PRISMA diagram of inclusion. 
  
Summary of Main Findings  
Refer to Table 1 for a complete list of included studies, study characteristics and main findings, 
as well as each studies covariates.  
A Finnish longitudinal cohort study by Korhonen et al.(21), among 192 mother-child dyads, 
found that prenatal depression was significantly associated with the 16-year-old child’s 
externalizing behavior problems. Notably, in this study population, maternal depression, when 
the child was 8-9-years-old, was not significantly associated with the child’s behavior problems, 
but when measured at the child’s age of 16 years it was associated with the child’s externalizing 
behavior problems(19). The study reported that children of women who had a ‘high stable’ 
trajectory of depressive symptoms from pregnancy to the child’s adolescence had the highest risk 
for externalizing problems, suggesting that both pre-and-postnatal depression increase the child’s 
risk(19).  
The Finnish Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction 
(PREDO) study by Lahti et al.(15)  of 2296 mother-child dyads found that higher maternal  
prenatal depressive symptoms  were associated with higher internalizing, externalizing and total 
psychiatric problems of the child aged 1.9-5.9 years. These effects were independent of maternal 
depressive symptoms measured at the childhood follow-up, suggesting that the harmful effects 
on the child outcomes are specific to the prenatal period. The effects were gestation-week non-
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specific, meaning that higher maternal depressive symptoms at the 14 biweekly measurements 
between 12-39 gestational weeks, were associated with more  problems  across a broad range of 
child behaviors(20). The study found that maternal depressive symptoms at the child follow-up 
partially mediated the prenatal depression effects. Additionally, the offspring of women who 
were consistently more depressed during pregnancy and at the childhood follow-up displayed the 
most problems(20), supporting the concept that both pre-  and postnatal factors play a role. 
In another study from the Finnish PREDO cohort by Wolford et al.(18), among 1779 mother-
child dyads, higher maternal depressive symptoms during pregnancy were  associated with 
significantly increased ADHD symptoms in children aged 3-6 years. These effects were 
independent of and partially mediated by maternal depressive symptoms measured in the 
childhood follow-up and were gestation-week non-specific; children of mothers with consistently 
high depressive symptoms both during pregnancy and in early childhood had the most ADHD 
symptoms (18). 
The German Franconian Cognition and Emotion Study(FRANCES)  study by Eicheler et al., 
which assessed children of 61 depressed and 143 non-depressed mothers, found that at age 6-9 
years, offspring of depressed mothers scored higher on anxiety, depression and antisocial 
behavior(21). The associations with child depression and anxiety were independent of maternal 
depressive symptoms measured at the child follow-up, pointing to prenatal specificity of these 
effects(21). Yet, it remains unknown if the prenatal depression effects on child antisocial 
behavior would have been explained by maternal depressive symptoms during the child follow-
up as the authors did not report these effects in the paper. This study also was unable to address 
if there would be a vulnerability window when maternal depressive symptoms  would have had 
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the most harmful offspring consequences, as the study measured  depressive symptoms only 
once, during the third pregnancy trimester(21).    
 In the Dutch Generation R study by El Marroun et al., among 5596 mother-child dyads,  1.5-6-
year-old children exposed to maternal depressive symptoms (without SSRIs) at 20 weeks of 
gestation showed more pervasive developmental problems than the control group(22). These 
associations remained significant after adjusting for maternal postnatal depression. Supplemental 
analysis indicated that prenatal depressive symptoms tended to be associated with autistic traits 
even after adjusted for maternal  depression at the child’s age of 3 years(23) . This study also 
measured affective problems and found an increased risk for affective problems in children who 
were exposed to prenatal maternal depression (without SSRIs)(23). With only one measure of 
prenatal depression, this study, however, leaves the vulnerability window unclear.  
In the UK  Avon Longitudinal Study of Parents and Children (ALSPAC) by Capron et al. among 
4303 mother-child dyads, higher maternal depressive symptoms at 18
th
 gestational week  were 
associated with and increased risk for anxiety disorder in the 18-year-old offspring(25).   
In another ALSPAC study by Leis et al. among 2891 mother-child dyads, higher maternal 
depressive symptoms  at 18
th
  and/or 32
nd
   gestational weeks were associated with higher risk of 
hyperactivity, emotional symptoms, conduct problems and total difficulties in the 11-year-old 
offspring (26).  When the child problems were rated by the child’s teacher, maternal prenatal 
depressive symptoms remained a significant predictor of the child’s hyperactivity(24).  
In the third ALSPAC study by O’Donnell et al. among 7944 mother-child dyads, maternal 
depressive symptoms at 18 weeks gestation predicted consistently elevated levels of the child’s 
behavior problems through ages 4 to 14 years(25).  
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All the ALSPAC study findings were independent of maternal postnatal depressive symptoms 
measured at the childhood follow-ups.  While the ALSPAC study has maternal depressive 
symptoms measurements at 18
th
 and 32
nd
 gestational weeks, these are not systematically reported 
in the studies, hence leaving open the question of a window of vulnerability.  
In another UK study by Plant et al., in the South London Child Development(SLCD) study of 
103 mother-child dyads  maternal depressive symptoms at 20 or 30 weeks of gestation were 
associated with an increased risk of depression in the 25-year-old offspring (26). In this study 
maternal prenatal depressive symptoms were correlated with maternal postnatal depressive 
symptoms measured up to 12 months after delivery. Yet, the postnatal depressive symptoms 
were not associated with the adult offspring depression. In contrast, children exposed to maternal 
depression in early childhood(1-6years) were at an increased risk for adult depression(26). This 
study also revealed an additive effect where each additional exposure to maternal depression 
measured at different developmental stages increased the risk of depressive symptoms in the 
offspring in adulthood(26). This study concluded that childhood maltreatment mediated the 
effect of maternal prenatal depressive symptoms on the child’s adulthood depression(28).  
In another US longitudinal study of 196 young, low income, African American mothers and their 
children, a path analysis indicated two indirect paths mediating the effects of maternal prenatal 
depression on toddler total behavior problems(27). One indirect path indicated a significant path 
of maternal prenatal depression on toddler total problems at 24 months via maternal sensitivity at 
24 months(27). The other indirect path showed that  maternal  depressive symptoms at 24 
months mediated the effect of maternal prenatal depression on toddler total behavior problems at 
24 months(27). It is unclear from this study whether prenatal depressive symptoms had effects 
on toddler behavior problems that were independent of maternal sensitivity and concurrent 
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depression. As this study measured maternal depressive symptoms only once during pregnancy, 
the  study was not able to address the question of specific vulnerability window(27).  
In another US study by Johnson, in a clinical subsample of 178 depressed mothers from the 
Emory Women’s Mental Health Program for perinatal mental illness, 2.5-5-year-old children 
exposed to maternal pregnancy depression (without SSRI) were  less likely to score in the ‘at-
risk range’ for pervasive developmental disorder than those exposed to SSRI(28). The post hoc 
nested sibling analysis found that the decreased likelihood for pervasive developmental disorder 
in children with depressed mothers without SSRIs to compared to those with SSRIs  remained 
significant(28).  
The US Californian registry study by Wieckowski et al., comprising nearly 9 million mother-
child dyads, found that maternal major depressive disorder(MDD; recurrent and single episode), 
dysthymia, depressive disorder not otherwise specified, and bipolar disorder increased the 4-21-
year-old offspring’s risk of autism spectrum disorder by 1.6-2.75-fold(21). While the timing of 
the maternal hospitalizations during pregnancy and at delivery were available, the study did not 
report the associations separately by trimesters or delivery; nor reported data on maternal 
hospitalizations during the child follow-up period. Hence, it remains unclear if the effects were 
specific to the prenatal period and if effects varied according to pregnancy trimester. 
Quality of the evidence  
We found the overall quality of the evidence as high to moderate based on the NOS Assessment, 
which judged cohort and case-control studies on three domains; 1)selection, 2)comparability, and 
3)outcome(Table 2 & Table 1).   
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The 13 prospective studies included in this review represent participants from 6 high income 
countries, 5 of which are European. The ALSPAC(n=3)(1,24,29) and SLCD studies(n=1)(26) 
both drew their cohorts from the southern UK population at around the same time-period. The 
PREDO(n=2)(20,30), MoBA(n=1)(31) and Korhonen et al.(n=1)(19)studies examined Nordic 
populations. The German FRANCES(21) and the Dutch Generation R study(22) both examined 
southern European populations with Generation R comprising a multi-ethnic European 
population.  In the US studies(n=3)(27,28,32), however, the populations’ distinct geographic, 
socioeconomic and clinical characteristics and ethnic variation, separate these three studies from 
each other. 
All of the studies used mother-child dyads(n=14), however, some studies used an additional 
caregiver measure(i.e. teacher or father)(n=3)(22,24,29), or a sibling comparison model 
(n=2)(28,31). Non-exposed participants were all drawn from the same populations as the 
exposed participants(1,19–22,24,26–32). Notably. there was one clinical subsample study(28). 
Only two studies used an objective maternal depression exposure measure, i.e medical records 
diagnosis(32)and the Clinical Interview Schedule (CIS) structured interview(26). Nine of the 
other studies used validated maternal report measures such as the Center for Epidemiological 
Studies Depression Scale(CES-D)(20,27,30), Edinburgh Postnatal Depression Scale(EPDS) 
(19,21) for measuring prenatal depressive symptoms. The bi-weekly CES-D measurements in the 
PREDO on maternal prenatal depression sets a gold standard for understanding the stability and 
trajectory of symptoms throughout gestation and allows for time point vulnerability 
exploration(20,30), a key tenant missing from the other studies in this review. The ALSPAC 
study also measured maternal depression at multiple prenatal and postnatal timepoints with the 
EPDS, however, only selective timepoints were used in each of the studies’ analyses(24–26,29). 
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The clinical subsample from the Emory Women’s Mental Health Program measured exposure 
using self-reports of SRI use and the Beck Depression Inventory, 2
nd
 Edition (BDI-II)(28). 
Although the BDI-II is a commonly used measure for depression in the general population, 
findings suggest questionable validity in prenatal and postnatal samples, especially when 
compared to the EPDS(33,34). The Norwegian MoBa study(31) used 3 selected items from the 
Symptoms Checklist(SCL) version 5 comprising an externally non-validated measure of 
maternal depressive symptoms(31). Internally, a Norwegian study reporting on the reliability and 
validity of the short form the psychometric measures used in the MoBA study, indicates a strong 
correlation between the 5 items in the SCL-8 short form and in 3 items in the SCL-5 with the 
original SCL-25 for depression(35). Authors, cited their previous work reporting a moderate 
level of agreement between the self-report and diagnostic interview measures, however using the 
5-item version of the SCL-5(36).  
For comparability, ten studies controlled for the sex of the offspring as the most important 
confounder(20–22,24–28,30,31), while three studies(19,29,32) did not control for sex, reducing 
comparability. All 13 studies controlled for at least one other important factor such as age, 
gestation length, current maternal depressive status, maternal pre-pregnancy obesity, gestational 
diabetes/hypertension, pre-eclampsia, smoking and alcohol use during pregnancy all of which 
may significantly impact the findings(See Table 1 for all covariates used in each analysis). 
Although one study, did not report any of the adjusted analysis in the paper, as the author's 
indicated that it had no effect on the results(21).  Select studies accounted for novel confounders 
such as childhood maltreatment in path analysis which significantly attenuated the results(26),  
paternal pre and postnatal depression or sibling analysis(28,31), both of which account for 
genetic and environmental effects supporting the prenatal programming hypothesis. Yet, 
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regarding the sibling analyses, maternal depressive symptoms show high continuity from 
pregnancy to postpartum(16,27), and the Gjerde MoBA  study(19) did not describe the level of 
differential exposure among siblings or the inter-correlations between antenatal and postpartum 
symptoms that would have been needed to assess whether multi-collinearity posed a concern for 
any analyses. Overall differences in adjustment for confounders decreased the comparability of 
the results across studies(19–22,24–32).  
Regarding outcomes, 3 studies used an objective neuropsychiatric outcome measure removing 
the subjectivity of parental report questionnaires via medical records diagnosis (32), the Clinical 
Interview Schedule-Revised (CIS-R)(29) validated in young adult populations for identifying 
anxiety and depression (37), and the Structured Clinical Interview (26).   All other studies (n=10) 
used mother/father/caregiver-rated questionnaires. Six studies used the Child Behavior 
Checklist(CBCL), which measures internalizing, externalizing and total problems, emotionally 
reactive, anxious/depressed, somatic, withdrawn, sleep, attention and aggressive behavior 
problems, and affective, anxiety, pervasive developmental, attention deficit/hyperactivity, and 
oppositional defiant problems alone(19,20,22,23,28,31) or in combination with the Youth Self 
Report(YSR)(19), or the Social Responsiveness Scale(22). Other studies measured parental 
reported symptoms using the Conners’ Hyperactivity Index for ADHD(30), the Brief Infant-
Toddler Social and Emotional Assessment (BITSEA), which assesses internalizing, 
externalizing, dysregulation and competence(27,38) and the SDQ for assessing prosocial 
behavior, hyperactivity, emotional symptoms, conduct problems, peer problems, and total 
difficulties(1,39). The FRANCES study measured internalizing and externalizing behaviors 
using a psychologist administered set of mother-rated questionnaires from the ICD-10 and DSM-
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IV which are not well-known and are available only in the German language; hence it remains 
challenging to evaluate their reliability and validity(21) . 
All 13 studies followed participants for a suitable length of time for the designated outcome of 
interest. Notably, however, the CBCL has only been validated for ages 1-5, and inclusion of 
some participants at age 6 could have impacted the results in the Generation R study (40% age 
6)(22). Nine studies retained adequate numbers for follow-up and clarified how the authors dealt 
with missing data(19–22,26–28,30,31). Originally a very large cohort, the long term follow up of 
the ALSPAC studies(n=3)(1,24,29) experienced a high attrition rate, especially by follow up at 
18 years(24,25,29). However, the long-term adulthood follow-up in the ALSPAC 
studies(24,25,29) and the US register study(32)is a valuable addition to the literature. Notably, 
although the majority of studies have sample sizes in the thousands(20,22,24,25,29–31), one 
even over 8,000,000(32)  five studies in this review have relatively small sample sizes(19,21,26–
28).  
Limitations for this review as a whole, include the small number of studies which met the 
inclusion criteria and a high risk of publication bias across the included studies. Furthermore, our 
data extraction was performed by only one author. One question pinpointed at the beginning of 
this review, e.g. a specific gestational vulnerability timepoint, could not be fully elucidated based 
on the current body of evidence and the lack of replication multi-point measures across studies. 
Discussion 
This review of 13 studies supports the previous findings reviewed by Van den Bergh et 
al.(2017), suggesting that prenatal depression is associated with adverse neuropsychiatric 
consequences on the offspring. Ten studies(19,20,22,24–30) favored the conclusion that the 
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effects of maternal depression on offspring neuropsychiatric outcomes are specific to the 
maternal pregnancy period and are not accounted for by depression after pregnancy. Two 
studies(21,32), however, did not address the pre vs postnatal specificity question, and 
another(31) concluded that the offspring neuropsychiatric effects are not specific to the prenatal 
period, but are rather a consequence of maternal depression during the offspring postnatal 
development. As discussed previously, the one dissenting study used non-validated measures of 
maternal depression, which hampers it’s reliability(31).  Importantly, maternal depression shows 
high continuity from pregnancy onwards, with study populations(20,30) indicating that in over 
50% of the women, clinically relevant depressive symptomatology during pregnancy persists 
after delivery. Therefore, the question of exposure timing during pregnancy or after delivery of 
the maternal effects may be difficult to disentangle because of statistical multi-collinearity 
problems. Only the PREDO cohort from this review, with 14 by-weekly gestational 
measurements of maternal depressive symptoms was able to address the question of a specific 
vulnerability window, which showed that the effects on child problem behaviors were gestation 
week non-specific(20,30). 
Pathways 
Prenatal depressive symptoms may influence child neuropsychiatric outcomes via multiple 
psychological, health behavior, and biological pathways. An important component of 
understanding theses pathways, involves disentangling the effects of other pregnancy and 
perinatal complications, which may contribute to the severity, duration, and complexity of 
maternal prenatal depression. For instance, recent meta-analyses and systematic reviews show 
that maternal obesity in early pregnancy is associated with an increased risk of depression during 
pregnancy(40,41). Also in the PREDO cohort, from a study not in this review, women with early 
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pregnancy overweight and obesity had consistently elevated depressive symptoms throughout 
pregnancy and after delivery(8).  Evidence suggests that gestational diabetes and hypertension 
spectrum disorders may also be associated with prenatal depression(42), but these findings 
remain controversial(8). 
Maternal cardio-metabolic conditions might contribute as one of the pathways, as a meta-
analysis found that maternal obesity predicted an increased risk of autism and ADHD, 
developmental delay and emotional/behavioral problems in children(43). Also, we  recently 
showed that maternal severe obesity in early pregnancy is associated with hyperactivity, sleep 
problems, conduct, externalizing and total problems, depressive symptoms, anxiety and ADHD 
problems in children(44). Gestational diabetes has repeatedly been associated with an increased 
risk of neuropsychiatric disorders, particularly of autism and schizophrenia in the offspring(45–
48). Yet, in the PREDO maternal obesity or gestational diabetes were not associated with 
mother-rated internalizing, externalizing or total psychiatric problems in 1.9-5.9-year-old 
children (20), but were associated with child neurodevelopmental delay(49).  
Prenatal depression also increases risks of preterm birth and low birth weight(42,50). Also in the 
PREDO cohort, maternal depressive symptoms during pregnancy predicted shorter gestation 
length(51). Preterm birth and low birth weight have been consistently shown to be risk factors 
for neuropsychiatric disorders(52–56), and in sibling comparisons(53,54). 
Evidence from a meta-analysis and from large population-based studies suggests that depressed 
mothers are more likely to smoke throughout pregnancy(42,57), and prenatal smoking has been 
repeatedly associated with the risk of neuropsychiatric disorders in the offspring(20,58,59). Also 
in the PREDO, prenatal smoking was associated with increased internalizing, externalizing total 
psychiatric and ADHD problems in children(20,30). 
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Biological Mechanisms 
The biological mechanisms possibly linking maternal depression and psychological distress more 
generally with offspring neuropsychiatric outcomes were reviewed in Van den Bergh et 
al.(2017)(2). According to this review, and studies published since, prenatal depression may be 
associated with child neurodevelopment via 1)alterations in hypothalamus-pituitary-
adrenal(HPA)-axis functioning, 2) functional and structural changes of related brain areas 
including amygdala and prefrontal cortex, 3)changes in autonomic nervous system and 4) 
immune system functioning and in gut microbiota(2,60,61). 
At population level, one of the most consistent biological changes in depression is altered 
cortisol levels, indicating altered HPA-axis functioning(2,62,63). However, studies linking 
maternal depression specifically during pregnancy with maternal or infant cortisol levels have 
yielded inconsistent findings(2,62,63). Yet, maternal HPA axis functioning during pregnancy has 
been linked with offspring neuropsychiatric problems(2). For instance, we recently showed that 
maternal licorice consumption during pregnancy predicted an over 3-fold risk of ADHD 
problems in the offspring(64) due to Glycyrrhizin, which inhibits the placental 11β-
hydroxysteroid dehydrogenase type 2(11βHSD2) enzyme. This enzyme protects the fetus from 
maternal glucocorticoids, hence leaving the fetus vulnerable to maternal glucocorticoid excess. 
Furthermore, structural and functional changes in the infant amygdala, which regulates HPA axis 
functioning, have been repeatedly reported as a consequence of prenatal depression(2,65–67) and 
are also associated with child psychopathology risk(68,69). Also, alterations in the functioning of 
the autonomic nervous system that also plays a key role in the stress response have been found in 
children exposed to prenatal depression(2).  
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Changes in inflammatory pathways and gut microbiota, as a consequence of prenatal depression, 
offer another route through which prenatal depression may affect child neuropsychiatric 
problems. Maternal prenatal cytokine levels present questions for epigenetic programming as 
cytokines may pass through the placenta(70).  Higher prenatal depression has also been directly 
associated with maternal inflammatory cytokine levels during pregnancy(71,72), but the findings 
are inconsistent. Correspondingly both anti-inflammatory drugs(73) and probiotics(74) have 
antidepressant effects. Prenatal levels of C-reactive protein(CRP), a key inflammatory marker, 
have been associated with offspring risk of different neuropsychiatric disorders (75–78), and 
prenatal depression is associated with offspring CRP levels(79).  Evidence for the gut microbiota 
pathway predominately stems from animal studies but two recent studies have shown microbiota 
changes in offspring exposed to prenatal depression(80,81). Nonetheless, the biological 
mechanisms involved warrant further research.   
Cellularly, depression-related changes in fetal biology studies have specifically focused on 
epigenetic modifications. There are several recent systematic reviews on the effects of maternal 
psychological distress during pregnancy and more specifically antenatal depression on placental 
and infant DNA methylation(2,82,83). Overall, these reviews state that the findings are 
inconsistent but many candidate gene studies have linked methylation of the NR3C1, the 
glucocorticoid-receptor gene, with maternal prenatal depression. Other potential, often 
examined, candidate genes include 11BHSD2, FKBP5, IGF2, SLC6A4, OXTR, CRH and 
BDNF, genes that also play roles in HPA axis regulation. Most studies have focused on either 
assessing placental DNA methylation or infant cord-blood methylation levels. The studies have 
identified some significant effects, which still need validation. Future larger epigenome-wide-
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association studies harmonizing and pooling data into meta-analyses will overcome the current 
single study limitations.  
Recent findings from the PREDO suggest that changes in placental gene expression and infant 
DNA cord blood methylation as well as morphological changes in placental structure may be 
among the mediating biological pathways between antenatal depressive symptoms and child 
psychiatric problems. Among approximately 60 PREDO participants, prenatal depressive 
symptoms were associated with higher placental mRNA levels of glucocorticoid and 
mineralocorticoid receptor genes. Findings which suggest higher placental glucocorticoid 
sensitivity (84,85). In a UK longitudinal study among 93 participants, we found that higher 
prenatal depressive symptoms were associated with reduced placental IGF2-2 mRNA levels and, 
particularly in the placentas of female fetuses, with altered mRNA levels of several genes 
regulating fetal glucocorticoid exposure(86).  Furthermore, among PREDO participants, 
maternal prenatal depressive symptoms were associated with lower infant epigenetic gestational 
age at birth, a biomarker of the developmental maturation level of the fetus. This biomarker 
predicted increased total and internalizing psychiatric problems in  boys, and partially mediated 
the effects of maternal prenatal depression on boys’ internalizing problems(87). Another PREDO 
study assessing placental morphology among 86 participants found less variation in placental 
villous barrier thickness of gamma-smooth muscle actin-negative villi in the placentas of 
antenatally depressed mothers, indicating reduced placental maturation, due to prenatal 
depression. This placental structural change predicted internalizing and total psychiatric 
problems in 60 toddlers(88).   
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Treatments of prenatal depression 
Predictors for full recovery from prenatal depression include the absence of maternal health 
concerns, low total parental stress status, and limited child behavior issues(89), while maternal 
sensitivity has been found to attenuate the effects of maternal prenatal depression on toddler total 
problems (27), all which underscore the need for a comprehensive treatment approach for 
prenatal depression. Antidepressant medication may offer an option as several reviews indicate 
the likelihood of serious harms is low (12–15). Although,  investigations into specific 
medications and classes of anti-depressants (90–92) complicate the literature, suggesting serious 
harmful effects, leading many doctors not to prescribe and/or many women refuse/discontinue 
medication in pregnancy(5).  Until the data on the safety and efficacy of antidepressant therapies 
is clearly defined, efforts should be concentrated to assess alternative therapies. Although, they 
stray from antidepressants, pregnant women have reported an interest in cognitive behavioral 
therapy(5), which recent review evidence suggests has robust effects for the treatment of women 
with MDD(93). However, due to a lack of resources and limited access to standard therapies: 
nearly half of diagnosed women fail to receive timely evidence-based treatment(94).  In lieu of 
standard delivery, online cognitive behavioral therapy interventions may serve as an effective 
measure for improving maternal perinatal mental health(95,96). Recent studies have considered 
the effectiveness of  relaxation practices through musical therapy(97), fish oil supplementation 
(98), dietary supplementation(99) and future studies could consider probiotics supplements.  
Conclusions  
Our review found a limited amount of high to moderate quality evidence supporting the 
association of prenatal depression and neuropsychiatric outcomes in children, published 2014-
2018. More, carefully conducted cohort studies with multi-time point, validated exposure and 
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outcome measures investigating epigenetic and protective factors are needed to further 
corroborate the findings relating to a specific developmental vulnerability period. Further 
investigations into the implications of the timing and consistency of exposure, confounding by 
other perinatal conditions, and possible biological mechanisms would bolster the evidence. 
Future research needs continuous and prospective measures of maternal depressive symptoms 
throughout pregnancy and beyond, in order to better scope the prenatal and postnatal trajectories 
of depression, risk factors, and include follow-up of offspring into adulthood to assess long-term 
neuropsychiatric effects.  
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Figure 1. PRISMA Flow Diagram: Study inclusion and exclusion process 
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Korhonen 
et al. 2014  
Finnish 
longitudinal 
cohort 
study  
Finnish mother-
child dyads  
192  cohort  
Prenatal: EPDS4  in the 
last trimester  
  
  
Postnatal: EPDS4   2 
weeks, 2 months, 6 
months, 4-5 years,  
8-9 years & 16-17 years  
CBCL1 &  
YSR11 at multiple 
times up to age 16  
  
Time of the initial exposure for  maternal depressive symptoms and  
adolescent CBCL/YSR outcomes were significant for the following:  
Initial Prenatal (Last trimester) exposure & externalizing problems: 
P=0.037, standard effect size 0.40 
(CBCL)    P=0.092. standard effect 
size 0.30 (YSR)  
Initial Postnatal (2 months) exposure & internalizing problems: P=0.030, 
standard effect size 0.90 (YSR) Initial Postnatal (16 years) exposure & 
externalizing problems: P=0.003, standard effect size 1.00 (YSR)  
Adjusted Covariates: Int.Epis.Time  
Lahti et al 
2017  
PREDO1  
Finnish, mother-
child dyads  
2296  cohort  
Prenatal: CES-D Bi-
weekly between 
weeks+days  
12+0/13+6 and 
38+0/39+6   or 
delivery.   
Postnatal: Becks 
Depression  
Inventory 1½−5 years  
CBCL6 at  ages 1.9-
5.9years  
Maternal depressive symptoms during 
pregnancy predicted significantly  higher 
internalizing (0.28 SD unit per SD unit increase  
[95% CI = 0.24, 0.32]), externalizing (0.26 [0.23, 
0.30]), and  total problems (0.31 [0.27, 0.35]) in 
children.   
Adjusted Covariates:  Hist.Dep, Antidep., Psycho.Meds, SDP, Par., PPH, 
M.Diab., Sex, GL, BWT, Fam.Stat., ADP, M.Edu,  
CA   
Wolford et 
al 2017  
PREDO  
Finnish, mother-
child dyads  
1779  cohort  
Prenatal: CES-D Bi-
weekly between 
weeks+days 
12+0/13+6 and 
38+0/39+6 or 
delivery. 
  
  
  
Postnatal: Becks 
Depression  
Inventory 1½−5 years  
CHI questions 
(ADHD) at 3-6 
years old  
Children of mothers with consistently high prenatal depressive symptoms 
showed higher average levels   
(MD = 0.46 SD units, 95% CI 0.36, 0.56, p < 0.001 compared to the low 
group),  
 and proportion (32.1% vs. 14.7%) and odds (OR = 2.80, 95% CI 2.20, 3.57, 
p < 0.001) of clinically significant ADHD symptoms.  
Adjusted Covariates: M.ADHD, Hist.Dep, Antidep., psycho.meds, SDP, pari., 
PPH, M.Diab., Sex, GL, BWT, Fam.Stat.,  
ADP,, M.Edu, CA   
NORWAY                  
Gjerde 
2017  
MoBA  
11,599 
Norwegian 
families   
17830  
siblings   
cohort  
 Prenatal: SCL-90 
Short form SCL-5 
and SCL-8 
selfrating 
questionnaires  
17th week & 30th 
week  
gestation    
Postnatal: 6 
months, 18 months, 
3 years & 5 years 
after birth  
  
CBCL6 at 1.5, 3 and 
5-years  
In sibling comparison, concurrent maternal 
depression was significantly  associated with 
internalizing [estimate = 2.82(1.91, 3.73, 95% 
CI)]  and externalizing problems [estimate = 
2.40(1.56, 3.23, 95% CI)] Adjusted Covariates: 
CA, Sex, Par., M.Edu  
GERMANY                  
Eichler et 
al 2017  
FRANCES  
German, mother-
child dyads 
randomly 
selected  
from the FRAMES  
study population    
204  case-control  
Prenatal: EPDS  3rd  
trimester
  
  
Postnatal: EPDS 6-9 
years  
  
Parental 
Questionnaire 
from ICD-10 and 
DSM-IV aged 6-9  
Total Sample: 6.74(4.95) , Mother not depressed: 4.04(2.59),  
Mother depressed: 13.07(3.01)  
Not-depressed vs. depressed: −21.7** P-value: 0.000  
Adjusted Covariates: Sex, Fam.Stat., CMD  
THE NETHERLANDS                
Table 
1 
: Summary of Included Study Characteristics & Main 
Findings 
  
Stud
y 
  Sourc
e 
  Populati
on 
  
Sampl
e  Siz
e 
  
Study 
Design 
  
Maternal 
Exposure  
  
Measureme
nt  
  
    Offspring 
Outcomes  Measureme
nts  
  
Result
s  
  
Statistical 
Analysis 
  
FINLAND                   
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El Marroun et 
Generation R al. 2014  
Dutch mothers-
child dyads & 
father-child 
dyads  
5976  Cohort  
Prenatal SSRI 
Exposure: 1) SSRI 
use self-report, 2) 
pharmacy 
prescription 
records  
    
Prenatal Depression  
Exposure: BSI12  at 20 
weeks gestation  
  
CBCL &   
SRS13 at ages 1.5, 3 
and 6 years  
Maternal depressive symptoms (without SSRIs) associated with mother 
rated child affective problems (OR=1.44, 95%CI 1.15, 1.81, P=0.001).   
Maternal depressive symptoms (without SSRIs) and Father ratings of 
child affective problems were also significant (OR=1.60, 95% CI 1.05, 
2.45, P=0.03)  
Prenatal depressive symptoms as a continuous variable were also 
associated with affective problems (OR= 1.35, 95% CI 1.13, 1.61, 
P=0.001).  
Maternal prenatal depressive symptoms (without SSRIs) exposed children 
had more pervasive developmental problems in clinical range (OR=2.02, 
95% CI 1.53, 2.66).  
Maternal prenatal depressive symptoms (without SSRIs) exposed children 
after adjusting for depression at age  
3 had more pervasive developmental problems. (OR=1.44, 95%CI 1.07, 
1.93, p=0.02)  
Maternal prenatal depressive symptoms were associated with autistic 
traits (β=0.05, 95% CI 0.01, 0.08,  
P=0.001)  
 
      Maternal prenatal depressive symptoms (continuous) associated with 
autistic traits (β=0.05, 95% CI 0.03, 0.07).   
Direct comparison of the effect estimates of SSRI use and depression 
symptoms without SSRI use (β=0.09, 95% CI 0.01, 0.17)  
Adjusted Covariates: MA, Sex, M.Edu, ethnicity, SDP, GA,CMD  
UNITED KINGDOM                
Capron 2014  ALSPAC14  
Avon region, UK 
Mother-Father-
Child triads  
4303  Cohort  
Prenatal: EPDS4  at 18 
weeks gestation  
Postnatal: EPDS4 8 weeks 
&  
 
 
21 months   
CIS-R16 at age 18 
years   
  
Children exposed to maternal prenatal depression at 18 weeks had 
increased risk of anxiety at age 18:  
 (Adjusted for postnatal depression at 8wks) OR=1.75 (95% CI 1.19, 2.58)*  
(Adjusted for postnatal depression at 21 months) 
OR=1.62 (95% CI 1.06, 2.47)* The risk from paternal 
prenatal depression at 18 weeks was not significant. 
Adjusted Covariates: MA, BWT, Par., ACDP, SDP, M.Edu, 
PNDA  
  
  
Leis et al 
2014  
ALSPAC14  
Avon region, UK 
Mother-Teacher-
Child triads  
2891  Cohort  
Prenatal: EPDS4 at 
18 & 32 weeks 
gestation    
  
Postnatal: EPDS4 at 8 
weeks,  
8, 21, 33, 61 & 73 
months  
SDQ17 at age 10-11 
years  
  
Children exposed to elevated levels of  maternal prenatal 
depression (>13 EPDS) at one time-points had increased 
scores (adjusted β (SE)) for:  
(hyperactivity) 0.35(0.13) p <0.01 (also significant for 
teacher rated SDQ)  
  
(emotional symptoms) 0.24 (0.09) p <0.01   
(conduct problems) 0.20 (0.08) p <0.01 (also significant 
for teacher rated SDQ) (peer problems) 0.21 (0.09) p 
<0.05  
(total problems) 1.00 (0.27) p <0.001 (also significant for 
teacher rated SDQ) Adjusted Covariates: Psycho.Vari., MA, 
BWT, Sex, SDP, ADP, M.Edu, Fam.Stat.  
or both of the  
O´Donnell et  
al. 2014  
  
ALSPAC  
Avon region, UK  
Mother-Child 
dyads  
7944  Cohort  
Prenatal: EPDS4 18 weeks  
gestation   4    
Postnatal: EPDS at 8 
weeks  
& 33 months postpartum  
SDQ17 at age  
4, 7, 9, 11.5 & 13 
years  
  
Intercept                        Estimate  
Maternal prenatal depression (32 
weeks)  0.077  
Maternal postnatal depression (8 
weeks)  0.127  
Maternal depression at 33 months 
post.  0.183  
Adjusted Covariates: MA, M.Edu, SES, 
BWT, GA, Sex, SDP, ADP, 
SE  
0.014  
0.014  
0.013  
 CMD, 
Pater. 
Est/SE  
5.597  
9.162  
13.776  
Anxi., 
Parent.Index 
p 
0.000  
0.000  
0.000  
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Plant et 
al. 2015  
SLCDS17  
UK mother-child 
dyads  
103  Cohort  
Prenatal: CIS-R16 at 
20 & 36 weeks 
gestation 
Postnatal:   
CIS-R16 at 3 months & 12  
months     
  
SADS-L18 at 4 years, 11, 
and  
16 years  
  
Structured Clinical  
Interview for DSM-IV 
Axis  
I Disorders at age 25  
  
Offspring exposed to maternal prenatal depression had an increased risk 
depressed in adulthood.  
OR=3.4(95% CI 1.15, 8.1) X2(1)=8.4, p=0.004  
Mean number of depressive symptoms was higher for those who were 
exposed to prenatal depression (M=3.4, SD 3.0)  
Than those unexposed (M=1.7, SD 2.(, z=-2.8, p=0.004).  
Maternal depression in the postnatal period up to 1 year was not 
associated with adult depression:  
OR=1.8, (95% CI 0.8, 4.2) X2(1)=2.1, p=0.15  
Maternal depression in offspring childhood (1-16 years) was associated 
with depression in adulthood  
OR=4.2 (95% CI 1.8, 10.2) ) X2(1)=11.1, p=0.001  
Maternal prenatal depression effects on offspring adult depression was 
mediated by childhood maltreatment B=0.39, (95% CI 0.04, 1.05)  
Adjusted Covariates: MA, ethnicity, SES, M.Edu, Fam.Stat., Psycho.Vari., His.Dep, 
SDP, ADP, GA, BWT, Sex, Ethnicity,  
C.Edu, C.IQ   
UNITED STATES OF 
AMERICA  
              
Edwards et al.  US 
longitudinal  
 2016  study  
Young, low SES, 
African 
American 
mother-child 
dyads  
196  Cohort  
Prenatal: CES-D during  
pregnancy     
Postnatal: CES-D at 
24 months  
BITSEA at age 24 
months  
  
Path analysis   
Prenatal Depression maternal Sensitivity  behavior problems   
(Full Sample) B(SE) 0.031 (0.020) 95%  CI (0.003, 0.083)*  
(Boys) B (SE) 0.052 (0.035) 95% CI (0.003, 0.147)*  
(Girls) B (SE) 0.002 (0.015) 95% CI (-0.023, 0.044)  
Prenatal Depression 24 month depression  behavior problems   
(Full Sample) B(SE) 0.086 (0.032) 95% CI (0.027, 0.152)*  
(Boys) B (SE) 0.073 (0.016) 95% CI (0.016, 0.044) *  
(Girls) B (SE)  0.097 (0.061) 95% CI (-
0.016, 0.225) Adjusted Covariates: Sex, mom-dad  
Johnson 2016 
 
Emor
y 
Women’s  
Clinical sample 
of USA Mother-
child-child triads  178  
Clinical, 
observational   
Prenatal:  
BDI7  during pregnancy 
   
Postnatal: BDI at follow-
up  
CBCL6 PDD15 in 
sibling pairs at 
ages 2.5-5 years  
  
Children exposed to prenatal depression (without SRI exposure) less likely 
to score in the high risk range on the PDD than those exposed to SRIs:  
                  
1. Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction  Adjusted Covariates: Antidep. (Antidepressant Use), 
ACDP (Alcohol Consumption During Pregnancy),  
2. Center for Epidemiologic Studies Depression Scale  Apgar(Apgar Score),BWT (Birthweight), CA(Child Age), 
C.EarlyLearn.(Child Early Learning Center  
3. Franconian Cognition and Emotion Studies( Follow-up study to the FRAMES cohort)  
4. Edinburgh Postnatal Depression Scale   attendance), C.Ethnicity (Child ethnicity), C.IQ (Child IQ score) C. 
Mal.(childhood maltreatment),  
5. Norwegian Mother and Child Cohort study  CMD(Concurrent Maternal Depression), Deliv.Meth.(Delivery Method), 
Deliv.Comp(Delivery Complications),   
6. Child Behavior Checklist   
7. Beck Depression Inventory/ Beck Depression Inventory II  Fam.Stat (Family Status),  GA(Gestational Age), GL(gestational length), 
GDH(Gestational  
8. Selective Serotonin Reuptake Inhibitors  Diabetes/Hypertension), Glob.Funct.(Global assessment of Functioning), 
HC(Head Circumference),  
9. Medically untreated depression group  Hist.Dep(History of Diagnosed Depression) , Int.Epis.Time (Initial episode 
timing), M.ADHD (Maternal ADHD),  
10. Control group  
11. Youth Self Reports  MA (Maternal Age), MDep(Maternal Prenatal Depressive Symptoms), M.Edu(Maternal Education 
Status), M.  
©    2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Review: Depression & Offspring 
12. Brief Symptom Inventory  Ethnicity (Maternal Ethnicity), M.Occup (Maternal Occupation/Status), 
M.Epilep.Stat.(Maternal Epileptic Status),  
13. Social Response Scale  MoodEpi.(Mood Episodes), Numb.Comp(Number of Pregnancy Complications), Par. (Parity),  
14. Avon Longitudinal Study of Parents and Children  
15. Pervasive Developmental Disorders (CBCL Subscale)  Pater.Anxi.(Paternal pre/postnatal Anxiety), Parent.Index(Parenting 
Index Score), PE(Pre-Eclampsia, Mom16.  Clinical Interview Schedule- Revised  dad(mother-father relationship), 
PD(paternal depression), PND(Postnatal depression), PNDA(Maternal Postnatal  
17. South London Child Development Study  Depression & Anxiety), PPObes.(Pre-Pregnancy Obesity),  
Psycho.Meds.(Psychotropic Medication use),  
18. Schedule for Affective Disorders and Schizophrenia   
Psycho.Vari.(Psychological Variables), 
SDP(Smoking During Pregnancy) 
  
  
Table 2. NOS Quality of Evidence (Table listed in order of source country and then alphabetically.)  
The Newcastle-Ottawa Scale assesses studies on 3 domains: Selection of study participants, Comparability of the studies, and the selection of the Outcomes. A study 
can receive a maximum of 4 stars in the Selection domain, 2 stars in the comparability domain, and 3 stars in the Outcomes domain.   
  
Quality  
Assessment 
Criteria  
 
Selection (⋆⋆⋆⋆)  
 
Comparability (⋆⋆)  
 
Outcome (⋆⋆⋆)  
 
Score  
Representativeness of 
exposed cohort?  
Selection of the 
non-exposed 
cohort?  
Ascertainment of 
exposure?  
Demonstration that 
outcome of interest 
was not present at start 
of study?  
Study 
controls 
for sex?  
Study controls for at least 
one additional 
factor?  
Assessment  
of 
outcome?  
Was follow-up long 
enough for 
outcome to occur?  
Adequacy 
of follow-up 
of cohorts?  
Overall  
Quality 
Score  
Acceptable  
(⋆)  
Representative 
of average in 
community   
Drawn from same 
community as 
exposed cohort  
Secured records,  
Structured 
interview  
Children not yet 
born, therefore 
outcome not yet 
possible.  
Yes  
Age, pre-pregnancy obesity, 
gestational length, current  
maternal depression status,  
gestational diabetes/hypertension,  
pre-eclampsia, smoking & alcohol 
use during pregnancy, mother- 
father relationship, paternal 
depression, childhood 
maltreatment  
Independent 
blind  
assessment, 
record 
linkage  
Follow-up time 
period sufficient to 
measure outcome  
Complete 
follow-up, or  
subjects lost to 
follow-up  
unlikely to 
introduce bias  
High1  
Moderate2 
Poor3  
Korhonen 
et al. 2014  
⋆  ⋆    ⋆    ⋆    ⋆  ⋆  High  
Lahti et al. 
2017  
⋆  ⋆    ⋆  ⋆  ⋆    ⋆  ⋆  High  
Wolford et 
al. 2017  
⋆  ⋆    ⋆  ⋆  ⋆    ⋆  ⋆  High  
Gjerde  et 
al. 2017  
⋆  ⋆    ⋆  ⋆  ⋆    ⋆  ⋆  High  
 Mental 
Health 
Program   
     (mother rated): β= -0.163 Unstandardized B coefficient -0.001 (95% CI <-
0.001, 0.002, P=0.048)*  
Adjusted Covariates: CA, Sex, MA, Fam.Stat., M.Occup., C.Early Learn., CMD, 
SDP, ADP, Antidep., Psycho.Meds, BWT, HC,Apgar, GA, Deliv.Meth., 
DelivComp, NumbComp, MDep, MoodEpi., Glob.Funct., M.Epilep.Stat.  
Wieckowski 
et al 2017  
Hospital 
discharge 
records  
California singleton  
births occurring 1/1/91-
 8951763 
12/31/08   
retrospective 
cohort  
Medical records  ICD-9-
CM  
code for Depressive 
disorder  
NOS 311.x Anytime in 
the    
prenatal or perinatal 
period  
  
California Dept. Of 
Developmental 
services diagnosis  
(Autism) age 4-
21years  
 Mothers diagnosed with one individual 
psychiatric condition were  1.2-2.8 times 
more likely to have a child who developed 
autism.  Mothers diagnosed with any one or 
more psychiatric condition  were twice as 
likely to have a child with autism compared 
with  unaffected or unreported women (RR = 
1.97; 95% CI 1.83, 2.12). Adjusted Covariates: 
M.Origin, MA, M.Edu, Ethnicity  
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Eichler et 
al. 2017  ⋆  ⋆    ⋆  ⋆  
⋆  
    ⋆  ⋆  High  
El Marroun 
et al. 2014  
  ⋆  ⋆    ⋆  ⋆  ⋆  ⋆      Moderate  
Capron  et 
al. 2014  
  ⋆  ⋆    ⋆    
⋆   
  ⋆  ⋆  ⋆  High  
Leis et al.  
2014  
  ⋆  ⋆    ⋆  ⋆  ⋆    ⋆    Moderate  
O’Donnell 
et al. 2014  
  ⋆  ⋆    ⋆  ⋆  ⋆    ⋆    Moderate  
  
  
  
Plant et al. 
2015  ⋆  ⋆  ⋆  ⋆  ⋆  ⋆  ⋆  ⋆  ⋆  High  
Edwards et 
al. 2016  
  ⋆  ⋆    ⋆  ⋆  
⋆  
  
  
⋆  ⋆  High  
Johnson et 
al. 2016  
  ⋆      ⋆  ⋆  ⋆  ⋆  ⋆  ⋆  Moderate  
Wieckowski 
et al 2017  
⋆  ⋆  ⋆  ⋆    ⋆  ⋆  ⋆  ⋆  High  
1 High quality
  
2 Moderate quality: ≥ 5⋆ (Additional requirements:  selection domain 2 stars AND comparability domain 1-2 stars AND 
outcome domain 1-3 stars)  
3 Poor quality: ≤ 4⋆ (Additional requirements: selection domain 0-1 stars OR comparability domain 0 stars OR outcome 
domain 0 stars)  
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